Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Sigma Company Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (191)
ARTG (188)
Listed medicine compliance report (4)
Cancellation or suspension (2)

Date

2026 (2)
2025 (5)
2024 (78)
2023 (7)
2022 (2)
2021 (39)
2020 (43)
2019 (19)
2018 (52)
2017 (42)
2016 (5)
2015 (33)
2014 (11)
2013 (17)
2012 (6)
2011 (9)
2010 (1)
2008 (3)
2007 (7)
2004 (2)
2003 (1)
2002 (1)

Search

Sponsor content

385 result(s) found, displaying 51 to 60

Guardian Co-Enzyme Q10 (450638)

3 June 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guardian Co-Enzyme Q10.
Guardian Glucosamine (450642)

3 June 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guardian Glucosamine.
Guardian Evening Primrose Oil (450640)

3 June 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Guardian Evening Primrose Oil.
Guardian Odourless Wild Fish Oil Cancelled under Section 30(1)(c) of the Act

4 July 2024

Cancellation by sponsor

Requested by Sigma Company Limited
Guardian Odourless Wild Fish Oil Cancelled under Section 30(1)(c) of the Act

4 July 2024

Cancellation by sponsor

Requested by Sigma Company Limited
PHARMACY CARE IBUPROFEN 200 mg film coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2024

Cancellation by sponsor

Requested by Sigma Company Limited
PHARMACY CARE Chesty Cough Forte oral liquid bottle Cancelled under Section 30(1)(c) of the Act

30 June 2024

Cancellation by sponsor

Requested by Sigma Company Limited
PHARMACY CARE One-A-Day Glucosamine Cancelled under Section 30(1)(c) of the Act

30 June 2024

Cancellation by sponsor

Requested by Sigma Company Limited
AMCAL Olive Leaf Extract Cancelled under Section 30(1)(c) of the Act

30 June 2024

Cancellation by sponsor

Requested by Sigma Company Limited
Pharmacy Care Olive Leaf Extract Cancelled under Section 30(1)(c) of the Act

30 June 2024

Cancellation by sponsor

Requested by Sigma Company Limited

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia